25 Norman Way
Over
Cambridge CB24 5QE
United Kingdom
44 1223 967 943
https://www.4basebio.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 84
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Heikki Lanckriet Ph.D. | CEO, Chief Scientific Officer & Executive Director | 441,2k | N/D | 1977 |
Mr. David Roth | CFO, Company Secretary & Executive Director | 317,9k | N/D | 1967 |
4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. It also offers access to its targeted non-viral delivery platform, Hermes. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
L'ISS Governance QualityScore di 4basebio PLC al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.